Prime Gene Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Prime Gene Therapeutics?

Prime Gene Therapeutics has 7 investors including Zqet Group And Beijing Capital Science and Technology Development Group.

Q: How much funding has Prime Gene Therapeutics raised to date?

Prime Gene Therapeutics has raised obfuscated.

Overview

Prime Gene Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Prime Gene Therapeutics

CB Rank

33265

Prime Gene Therapeutics is a pharmaceutical company.

Founded

obfuscation

Private

Series B

Fengtai, Beijing, China

11-50

en.primegene.net/

Emergency Medicine

Health Care

Medical

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

Beijing Puqi Pharmaceutical Technology Co., Ltd.

Also Known As

Prime Gene

Operating Status

Active

Company Type

For Profit

About the Company

Prime Gene Therapeutics is committed to becoming a pharmaceutical company. They focus on new drug discovery, R&D, and commercialization in inflammatory diseases and external use. They are also developing and industrialization of innovative drugs.

Phone Number

010-83141848

Contact Email

pg@primegene.net

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

PG-011 (Pumecitinib) Gel

A topical JAK1/2 inhibitor gel for treating immune-inflammatory skin diseases such as atopic dermatitis and prurigo nodularis.

PG-011 Nasal Spray

A nasal spray formulation of pumecitinib for treating allergic rhinitis by inhibiting JAK1/2 pathways.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Prime Gene Therapeutics	5	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Zqet Group	—	Series B - Prime Gene Therapeutics	—
Zqet Group	—	Series B - Prime Gene Therapeutics	—
Zqet Group	—	Series B - Prime Gene Therapeutics	—
Zqet Group	—	Series B - Prime Gene Therapeutics	—
Zqet Group	—	Series B - Prime Gene Therapeutics	—